To study role of oral zinc in pneumonia
Not Applicable
- Conditions
- Health Condition 1: null- Pneumonia
- Registration Number
- CTRI/2018/07/014968
- Lead Sponsor
- Dr Kashmira Rajesh Mutha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Hospitalized children from age 2 months till 12 years
2.Diagnosed as pneumonia based on following criteria:
A.Fever, cough, difficulty in breathing B. B. B.Tachypnea (with/without chest retractions) defined as per WHO /IMCI age specific criteria
a)2 months to 12 months: Respiratory Rate > 50
b)12 months till 5 years: Respiratory Rate > 40
c) >5 years: Respiratory Rate >30
Exclusion Criteria
1.Recurrent Pneumonia
2.Congenital Heart Disease
3.Severe Acute Malnutrition
4.Tuberculosis
5.Children on zinc supplements
6.Documented allergy /Intolerance to zinc
7.Chronic systemic illness
8.Congenital GI malformations
9.Hyper-reactive Airway Disease
10.Radiological findings inconsistent with diagnosis of pneumonia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the effect of oral zinc supplementation on time required for clinical recovery of pneumonia in pediatric patient.Timepoint: Till clinical recovery of pneumonia.
- Secondary Outcome Measures
Name Time Method 1.To study the effect of oral zinc supplementation on total number of days of hospitalization. <br/ ><br>Timepoint: Till discharge from hospital;To study the side effects of zinc.Timepoint: Till discharge from hospital